| This article has been cited by |
| 1 | Carbamazepine-, Oxcarbazepine-, Eslicarbazepine-Associated Movement Disorder: A Literature Review | |
| Jamir Pitton Rissardo,Ana Letícia Fornari Caprara |
| Clinical Neuropharmacology.2020;43(3)66 |
| [DOI] |
|
| 2 | Drug-induced dystonia | |
| T. M. Ostroumova,V. A. Tolmacheva,O. D. Ostroumova,V. A. Parfenov |
| Neurology, Neuropsychiatry, Psychosomatics.2020;12(5)4 |
| [DOI] |
|
| 3 | Hyperkinetic Movement Disorder Emergencies | |
| Giovanni Cossu,Carlo Colosimo |
| Current Neurology and Neuroscience Reports.2017;17(1)4 |
| [DOI] |
|
| 4 | Hyperkinetic Movement Disorder Emergencies | |
| Janu Verma,Heng Luo,Heng Jianying Hu,Ping Zhang |
| Current Neurology and Neuroscience Reports.2017;17(1)260 |
| [DOI] |
|
| 5 | Movement disorders associated with antiseizure medications: A systematic review | |
| Daniel J. Zhou,Spriha Pavuluri,Isha Snehal,Cynthia M. Schmidt,Miguel Situ-Kcomt,Olga Taraschenko |
| Epilepsy & Behavior.2022;131(1)108693 |
| [DOI] |
|
| 6 | Causality, Severity, and Avoidability of Adverse Drug Reactions in Hospitalized Children: A Prospective Cohort Study | |
| Saurabh Gupta,Syed A Zaki,Sanjeevani Masavkar,Preeti Shanbag |
| Cureus.2023;131(1)108693 |
| [DOI] |
|
| 7 | Antiseizure Drugs and Movement Disorders | |
| Michel Sáenz-Farret,Marina A. J. Tijssen,Dawn Eliashiv,Robert S. Fisher,Kapil Sethi,Alfonso Fasano |
| CNS Drugs.2022;36(8)859 |
| [DOI] |
|
